9 Stories in coverage 53 approved Programs 97 recruiting Registered trials 424B3 Sep 25 Latest SEC filing Sep 21 Latest story
Timeline 9 Pipeline 5 Trials 9
All9 Trials and readouts4 Filings and people5
Pipeline by stage
Approved 3 Other 2
Details
Headquarters Dublin 4, L2 Industry Pharmaceutical Preparations Formerly ANTLER SCIENCE TWO PLC (to 2011); Antler Science Two Ltd (to 2011) Also known as Alkermes plc., ALKS, Antler Science Two Ltd, ANTLER SCIENCE TWO PLC How the company describes itself Alkermes develops neuroscience medicines including commercial products for alcohol dependence, opioid dependence, schizophrenia, bipolar I disorder, and narcolepsy. The company has late-stage clinical candidates for narcolepsy and idiopathic hypersomnia, and orexin 2 receptor agonists in early development for ADHD and fatigue in multiple sclerosis and Parkinson's disease. Headquartered in Ireland with operations in Massachusetts and Ohio. source
